1. Home
  2. UPBD vs BHVN Comparison

UPBD vs BHVN Comparison

Compare UPBD & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • BHVN
  • Stock Information
  • Founded
  • UPBD 1986
  • BHVN 2013
  • Country
  • UPBD United States
  • BHVN United States
  • Employees
  • UPBD N/A
  • BHVN N/A
  • Industry
  • UPBD Diversified Commercial Services
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPBD Consumer Discretionary
  • BHVN Health Care
  • Exchange
  • UPBD Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • UPBD 1.5B
  • BHVN 1.5B
  • IPO Year
  • UPBD 1995
  • BHVN 2017
  • Fundamental
  • Price
  • UPBD $25.02
  • BHVN $13.92
  • Analyst Decision
  • UPBD Buy
  • BHVN Strong Buy
  • Analyst Count
  • UPBD 4
  • BHVN 15
  • Target Price
  • UPBD $34.50
  • BHVN $56.07
  • AVG Volume (30 Days)
  • UPBD 587.5K
  • BHVN 2.1M
  • Earning Date
  • UPBD 10-30-2025
  • BHVN 11-11-2025
  • Dividend Yield
  • UPBD 6.24%
  • BHVN N/A
  • EPS Growth
  • UPBD 78.87
  • BHVN N/A
  • EPS
  • UPBD 1.79
  • BHVN N/A
  • Revenue
  • UPBD $4,481,986,000.00
  • BHVN N/A
  • Revenue This Year
  • UPBD $9.99
  • BHVN N/A
  • Revenue Next Year
  • UPBD $8.44
  • BHVN $2,002.87
  • P/E Ratio
  • UPBD $13.96
  • BHVN N/A
  • Revenue Growth
  • UPBD 7.49
  • BHVN N/A
  • 52 Week Low
  • UPBD $19.65
  • BHVN $12.79
  • 52 Week High
  • UPBD $36.00
  • BHVN $55.70
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 52.91
  • BHVN 41.13
  • Support Level
  • UPBD $24.39
  • BHVN $13.63
  • Resistance Level
  • UPBD $25.59
  • BHVN $17.05
  • Average True Range (ATR)
  • UPBD 0.65
  • BHVN 0.87
  • MACD
  • UPBD -0.01
  • BHVN -0.23
  • Stochastic Oscillator
  • UPBD 34.81
  • BHVN 8.01

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: